- How is kidney cancer treated?
- Surgery for kidney cancer
- Other local treatments for kidney cancer
- Active surveillance for kidney cancer
- Radiation therapy for kidney cancer
- Targeted therapies for kidney cancer
- Biologic therapy (immunotherapy) for kidney cancer
- Chemotherapy for kidney cancer
- Pain control for kidney cancer
- Clinical trials for kidney cancer
- Complementary and alternative therapies after kidney cancer
Biologic therapy (immunotherapy) for kidney cancer
The goal of biologic therapy is to boost the body’s own immune system to help fight off or destroy cancer cells. Because biologic therapy can be hard to give and can cause serious side effects, many doctors now save it for people who have advanced kidney cancers that don’t respond to targeted drugs.
The main immunotherapy drugs used for kidney cancer are cytokines (man-made versions of immune system proteins), such as interleukin-2 (IL-2) and interferon-alfa. These drugs can shrink kidney cancers in a small number of patients.
The side effects of immunotherapy can be severe and, rarely, fatal. For this reason, this treatment is only given by doctors experienced in their use, often in the hospital.
To learn more about specific biologic therapies, please see our document Kidney Cancer - (Adult) Renal Cell Carcinoma.
Last Medical Review: 04/29/2014
Last Revised: 04/29/2014